OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Risk of diabetic ketoacidosis of SGLT2 inhibitors in patients with type 2 diabetes: a systematic review and network meta-analysis of randomized controlled trials
Shiwen Yang, Ying Liu, Shengzhao Zhang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 15
Shiwen Yang, Ying Liu, Shengzhao Zhang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 15
Showing 15 citing articles:
Risk of Diabetic Ketoacidosis Associated with Sodium Glucose Cotransporter-2 Inhibitors: A Network Meta-Analysis and Meta-Regression
Kannan Sridharan, Gowri Sivaramakrishnan
Journal of Clinical Medicine (2024) Vol. 13, Iss. 6, pp. 1748-1748
Open Access | Times Cited: 7
Kannan Sridharan, Gowri Sivaramakrishnan
Journal of Clinical Medicine (2024) Vol. 13, Iss. 6, pp. 1748-1748
Open Access | Times Cited: 7
Comparative efficacy of sodium glucose cotransporter-2 inhibitors in the management of type 2 diabetes mellitus: A real-world experience
Lubna Islam, Dhanya Jose, Mohammed Alkhalifah, et al.
World Journal of Diabetes (2024) Vol. 15, Iss. 3, pp. 463-474
Open Access | Times Cited: 4
Lubna Islam, Dhanya Jose, Mohammed Alkhalifah, et al.
World Journal of Diabetes (2024) Vol. 15, Iss. 3, pp. 463-474
Open Access | Times Cited: 4
Clinical Perspectives for Diagnosis and Treatment of Diabetic Cardiomyopathy
David Chen, Andrew Sindone, Michael Huang, et al.
(2025)
Closed Access
David Chen, Andrew Sindone, Michael Huang, et al.
(2025)
Closed Access
Risk of diabetic ketoacidosis caused by sodium glucose cotransporter-2 inhibitors in patients with type 1 diabetes: a systematic review and network meta-analysis of randomized controlled trials
Ying Liu, Shiwen Yang, Aidou Jiang, et al.
Frontiers in Endocrinology (2025) Vol. 15
Open Access
Ying Liu, Shiwen Yang, Aidou Jiang, et al.
Frontiers in Endocrinology (2025) Vol. 15
Open Access
Diabetic Ketoacidosis and the Use of New Hypoglycemic Groups: Real-World Evidence Utilizing the Food and Drug Administration Adverse Event Reporting System
Hilal Thaibah, Otilia J.F. Banji, David Banji, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 2, pp. 214-214
Open Access
Hilal Thaibah, Otilia J.F. Banji, David Banji, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 2, pp. 214-214
Open Access
Illnesses associated with ketosis including diabetic ketoacidosis during very low carbohydrate and ketogenic diets
Caroline G. P. Roberts, Shaminie J. Athinarayanan, Robert E. Ratner, et al.
Diabetes Obesity and Metabolism (2025)
Open Access
Caroline G. P. Roberts, Shaminie J. Athinarayanan, Robert E. Ratner, et al.
Diabetes Obesity and Metabolism (2025)
Open Access
Sodium‐Glucose Cotransporter‐2 Inhibitors and Diabetic‐Ketoacidosis in T2DM Patients: An Updated Meta‐Analysis and a Mendelian Randomization Analysis
Yufei Wang, Yuhan Qin, Jing Zhang, et al.
Clinical Pharmacology & Therapeutics (2025)
Closed Access
Yufei Wang, Yuhan Qin, Jing Zhang, et al.
Clinical Pharmacology & Therapeutics (2025)
Closed Access
Audrey K. Cook, Ellen N. Behrend
Journal of Veterinary Pharmacology and Therapeutics (2024)
Open Access | Times Cited: 3
SGLT2 inhibitors for the treatment of diabetes: a patent review (2019–23)
Rahul Baghel, Nikita Chhikara, Pawan Kumar, et al.
Expert Opinion on Therapeutic Patents (2024) Vol. 34, Iss. 9, pp. 807-823
Closed Access | Times Cited: 2
Rahul Baghel, Nikita Chhikara, Pawan Kumar, et al.
Expert Opinion on Therapeutic Patents (2024) Vol. 34, Iss. 9, pp. 807-823
Closed Access | Times Cited: 2
Empagliflozin: primum inter pares among sodium-glucose cotransporter-2 inhibitors?
Giuseppe Biondi‐Zoccai, Giacomo Frati, Mariangela Peruzzi, et al.
Journal of Cardiovascular Pharmacology (2024) Vol. 84, Iss. 3, pp. 271-275
Closed Access | Times Cited: 1
Giuseppe Biondi‐Zoccai, Giacomo Frati, Mariangela Peruzzi, et al.
Journal of Cardiovascular Pharmacology (2024) Vol. 84, Iss. 3, pp. 271-275
Closed Access | Times Cited: 1
Overview of diabetes agents in cardiovascular disease: it takes an orchestra to play Tchaikovsky in symphony
Wann Jia Loh
Current Opinion in Endocrinology Diabetes and Obesity (2024) Vol. 32, Iss. 1, pp. 3-11
Closed Access | Times Cited: 1
Wann Jia Loh
Current Opinion in Endocrinology Diabetes and Obesity (2024) Vol. 32, Iss. 1, pp. 3-11
Closed Access | Times Cited: 1
New insights into the cardio-renal benefits of SGLT2 inhibitors and the coordinated role of miR-30 family
Abdellatif El Khayari, Soukaina Miya Hakam, Gabriel Malka, et al.
Genes & Diseases (2023) Vol. 11, Iss. 6, pp. 101174-101174
Open Access | Times Cited: 2
Abdellatif El Khayari, Soukaina Miya Hakam, Gabriel Malka, et al.
Genes & Diseases (2023) Vol. 11, Iss. 6, pp. 101174-101174
Open Access | Times Cited: 2
Perioperative management in patients treated with gliflozins
Michal Šitina, Vladimír Šrámek
Anesteziologie a intenzivní medicína (2024) Vol. 35, Iss. 3, pp. 162-167
Closed Access
Michal Šitina, Vladimír Šrámek
Anesteziologie a intenzivní medicína (2024) Vol. 35, Iss. 3, pp. 162-167
Closed Access
Successful renal replacement therapy of extreme ertugliflozin and alcohol induced euglycaemic ketoacidosis
A. Holstein, Jonas A. Linck, Johann Christoph Blaue, et al.
Acta Diabetologica (2024)
Closed Access
A. Holstein, Jonas A. Linck, Johann Christoph Blaue, et al.
Acta Diabetologica (2024)
Closed Access
SGLT2 Inhibitor-Induced Euglycemic Diabetic Ketoacidosis (EDKA) in Patients With Underlying Risk Factors
Paul Joseph Solinsky, Axel Holstege, Glen Burnie
Annals of Pharmacotherapy (2024)
Closed Access
Paul Joseph Solinsky, Axel Holstege, Glen Burnie
Annals of Pharmacotherapy (2024)
Closed Access
